The market anticipates continued poor revenue growth, possib...
The market anticipates continued poor revenue growth, possibly suppressing the P/S ratio. The company's projected growth is below industry average, potentially causing shareholder pessimism and a depressed P/S. A change in fortune is needed for the P/S to rise.
Revenues Working Against Shandong Kexing Bioproducts Co,.Ltd's (SHSE:688136) Share Price Following 26% Dive
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment